Evidence map›Paper›PMID 37207151›Full record

ArticleFrontiers in oncology2023

Educational level-dependent melanoma awareness in a high-risk population in Switzerland.

Alina Miriam Mueller, Elisabeth Victoria Goessinger, Sara Elisa Cerminara, Lisa Kostner, Margarida Amaral, Stephanie Marie Huber, Lea Pauline Passweg, Laura Garcia Moreno, Daniel Bodenmann, Michael Kunz and 5 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alina Miriam MuellerDepartment of Dermatology, University Hospital of Basel, Basel, Switzerland.
Elisabeth Victoria GoessingerDepartment of Dermatology, University Hospital of Basel, Basel, Switzerland.
Sara Elisa CerminaraDepartment of Dermatology, University Hospital of Basel, Basel, Switzerland.
Lisa KostnerDepartment of Dermatology, University Hospital of Basel, Basel, Switzerland.
Margarida AmaralDepartment of Dermatology, University Hospital of Basel, Basel, Switzerland.
Stephanie Marie HuberDepartment of Dermatology, University Hospital of Basel, Basel, Switzerland.
Lea Pauline PasswegFaculty of Medicine, University of Basel, Basel, Switzerland.
Laura Garcia MorenoFaculty of Medicine, University of Basel, Basel, Switzerland.
Daniel BodenmannFaculty of Medicine, University of Basel, Basel, Switzerland.
Michael KunzDepartment of Dermatology, University Hospital of Basel, Basel, Switzerland.
Mitchell Paul LevesqueDepartment of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
Julia-Tatjana MaulDepartment of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
Phil Fang ChengDepartment of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
Alexander Andreas NavariniDepartment of Dermatology, University Hospital of Basel, Basel, Switzerland.
Lara Valeska MaulDepartment of Dermatology, University Hospital of Basel, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The worldwide incidence of melanoma has been increasing rapidly in recent decades with Switzerland having one of the highest rates in Europe. Ultraviolet (UV) radiation is one of the main risk factors for skin cancer. Our objective was to investigate UV protective behavior and melanoma awareness in a high-risk cohort for melanoma. Methods: In this prospective monocentric study, we assessed general melanoma awareness and UV protection habits in at-risk patients (≥100 nevi, ≥5 dysplastic nevi, known CDKN2A mutation, and/or positive family history) and melanoma patients using questionnaires. Results: Between 01/2021 and 03/ 2022, a total of 269 patients (53.5% at-risk patients, 46.5% melanoma patients) were included. We observed a significant trend toward using a higher sun protection factor (SPF) in melanoma patients compared with at-risk patients (SPF 50+: 48% [n=60] vs. 26% [n=37]; p=0.0016). Those with a college or university degree used a high SPF significantly more often than patients with lower education levels (p=0.0007). However, higher educational levels correlated with increased annual sun exposure (p=0.041). Neither a positive family history for melanoma, nor gender or Fitzpatrick skin type influenced sun protection behavior. An age of ≥ 50 years presented as a significant risk factor for melanoma development with an odd's ratio of 2.32. Study participation resulted in improved sun protection behavior with 51% reporting more frequent sunscreen use after study inclusion. Discussion: UV protection remains a critical factor in melanoma prevention. We suggest that melanoma awareness should continue to be raised through public skin cancer prevention campaigns with a particular focus on individuals with low levels of education.

Indexed as

awarenesseducationmelanomapreventionsunscreen

Identifiers

PMID37207151
PMCPMC10189064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.